Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat

Psychopharmacology

Volumn 155, Issue 4, 2001, Pages 348-361

  Olausson, Peter ^a   Åkesson, Pernilla ^a   Petersson, Annelie ^a   Engel, Jorgen A ^a   Söderpalm, Bo ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5, 7 DHT; Behavioral disinhibition; Behavioral sensitization; Dopamine; Elevated plus maze; Locomotor activity; Microdialysis; Nicotine; Serotonin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; NICOTINE; QUINPIROLE; SEROTONIN;

ADAPTATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EFFECT; HUMAN; LOCOMOTION; MALE; MAZE TEST; MICRODIALYSIS; MOTIVATION; NEUROCHEMISTRY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; RECEPTOR INTRINSIC ACTIVITY; SENSITIZATION; SEROTONINERGIC SYSTEM;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DOPAMINE; DOPAMINE AGONISTS; EXTRACELLULAR SPACE; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 0034995278     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100710     Document Type: Article

References (100)

1. Impulsivity and history of drug dependence
2. Impairment of social and moral behavior related to early damage in human prefrontal cortex
3. The modulation of dopaminergic neurotransmission by norepinephrine
4. The induction of serotonin3-like receptor supersensitivity and dopamine receptor subsensitivity in the rat medial prefrontal cortex after the intraventricular administration of the neurotoxin 5, 7-dihydroxytryptamine: A microiontophoretic study
5. Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze
6. Sensitization of the mesoaccumbens dopamine response to nicotine
7. Different contributions of the human amygdala and ventromedial pre-frontal cortex to decision-making
8. The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain
9. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
10. Activation of transcription factor genes in striatum by cocaine: Role of both serotonin and dopamine systems
11. Impulsivity and cigarette smoking: Delay discounting in current, never, and ex-smokers
12. Dopamine-containing systems in the CNS
13. 5-HT1A receptor agonists reduce ethanol-induced locomotor activity in mice
14. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat
15. Enhanced quinpirole response in rats lesioned neonatally with 5, 7-dihydroxytryptamine
16. Serotonin release contributes to the locomotor stimulant effects of 3, 4-methylenedioxy-methamphetamine in rats
17. Inhibition of locus coeruleus neurons by serotonin at high doses
18. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats
19. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats
20. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine
21. Serotonin neurotransmission in cocaine sensitization
22. Neuropsychology. Towards a neuropathology of emotion and mood
23. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
24. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
25. Citalopram and 8-OH-DPAT attenuate nicotine-induced excitation of central noradrenaline neurons
26. Neurochemical aspects of the euphoria induced by dependence-producing drugs
27. The effect of long-term ethanol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens
28. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
29. Modified coeruleo-cortical noradrenergic neuro-transmission after serotonin depletion by PCPA: Electrophysiological studies in the rat
30. Altered neuronal responsiveness to biogenic amines in rat cerebral cortex after serotonin denervation or depletion
31. Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats
32. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: Comparison of injection sites
33. Modulation of the firing activity of noradrenergic neurons in the rat locus coeruleus by the 5-hydroxtryptamine system
34. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens
35. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons
36. Preexposure sensitizes rats to the rewarding effects of cocaine
37. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine
38. Subsensitivity of dopamine-stimulated cAMP response in rat striatal and medial frontal cortex slices following treatment with dopamine agonists
39. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the brain
40. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli
41. Induction but not expression of behavioural sensitization to nicotine in the rat is dependent on glucocorticoids
42. The pharmacology and neural circuitry of sensitization to psychostimulants
43. Serotonergic modulation of midbrain dopamine systems
44. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine
45. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine
46. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls
47. Personality traits and platelet monoamine oxidase in tobacco smokers
48. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
49. Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies
50. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine
51. Behavioral sensitization to cocaine: Modulation by the cyclic AMP system in the nucleus accumbens
52. From motivation to action: A review of dopaminergic regulation of limbic → nucleus accumbens → ventral pallidum → pedunculopontine nucleus circuitries involved in limbic motor integration
53. Ionic composition of microdialysis perfusion solution alters the pharmacological responsiveness and basal outflow of striatal dopamine
54. Locomotion induced by ventral tegmental microinjections of a nicotinic agonist
55. Molecular and cellular basis of addiction
56. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
57. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat
58. 5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones
59. Myths about the treatment of addiction
60. Behavioral sensitization to nicotine is associated with behavioral disinhibition: Counteraction by citalopram
61. Effects of serotonergic manipulations on the behavioral sensitization and disinhibition associated with repeated amphetamine treatment
62. 3 mediated control of dopaminergic function
63. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration
64. Stress and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration
65. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
66. Predisposition to self-administer amphetamine: The contribution of response to novelty and prior exposure to the drug
67. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens
68. Increasing effects of repetitive cocaine administration in the rat
69. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocryptine: Effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation
70. 3H]-5-hydroxytryptamine release from rat striatal synaptosomes
71. Effects of systemic nicotine on serotonin release in rat brain
72. Drug addiction: Bad habits add up
73. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release
74. The neural basis of drug craving: An incentive-sensitization theory of addiction
75. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms
76. Biochemical pharmacology of midbrain dopamine neurons
77. Suicidal behavior, impulsiveness and serotonin
78. Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine
79. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists
80. Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy
81. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis
82. Sensitization to the conditioned rewarding effects of cocaine: Pharmacological and temporal characteristics
83. Serotonergic involvement in conflict behaviour
84. A/benzodiazepine chloride ionophore receptor complex in the 5, 7-DHT induced anticonflict effect
85. A receptors
86. Reconciling the role of central serotonin neurons in human and animal behavior
87. Neurobiology of impulsivity and the impulse control disorders
88. Impulsivity and serotonergic function in compulsive personality disorder
89. Serotonin-immunoreactive neurons and their projections in the CNS
90. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats
91. Effects of the 5-HT agonist, 8-OH-DPAT, on ethanol preference in the rat
92. Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization
93. Differential regulation of D2 receptor gene expression by transcription factor AP-1 in cultured cells
94. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232: A microdialysis study
95. A psychomotor stimulant theory of addiction
96. Brain dopamine and reward
97. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization